Malaysia set to become Hepatitis C treatment hub of Asia
16 Nov 2021 //
BIOSPECTRUMASIA
Ascletis` All-oral HCV Treatment Approved for Marketing in China
31 Jul 2020 //
PRNEWSWIRE
WHO HCV Guidelines recommends Ascletis` Ravidasvir
09 Aug 2018 //
BIOSPECTRUM
Ascletis` NDA for Its All-oral HCV Treatment Accepted by CFDA
02 Aug 2018 //
PR NEWSWIRE
Making Hong Kong history, Ascletis eyes $457M haul in GIC-backed IPO
18 Jul 2018 //
ENDPTS
Epclusa`s fast-tracked Chinese approval might be late for Gilead
31 May 2018 //
FIERCE PHARMA